The Claim
Activation of adenosine A1 receptors in human neuroblastoma SH-SY5Y cells increases the production of soluble amyloid precursor protein fragments via a protein kinase C-dependent pathway.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In human neuroblastoma SH-SY5Y cells, activating adenosine A1 receptors leads to increased production of soluble amyloid precursor protein fragments through a biochemical pathway involving protein kinase C.
See the scientific wording
Adenosine A1 receptor activation in human neuroblastoma SH-SY5Y cells increases the production of soluble amyloid precursor protein fragments through a protein kinase C-dependent pathway, suggesting a potential biochemical link between A1 signaling and amyloidogenic processing.
When a specific receptor on nerve cells detects adenosine, it turns on a molecular switch called PKC, which activates another protein called Ras, which then turns on ERK. This chain of events changes how a larger brain protein is cut, producing more soluble fragments that are linked to Alzheimer's disease.
What the research says
1 studyIn lab-grown human nerve cells, activating a specific receptor (A1) caused more of a brain protein fragment to be made — the same fragment linked to Alzheimer’s disease — and this happened through a known molecular switch (PKC), just like the claim said.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.